由自发的尾部管状突变驱动的Acinetobacter菌体vB_Ab4_Hep4的宿主范围扩大
Penggang He1, Feng Cao2, Qianyu Qu1
1West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Frontiers in cellular and infection microbiology
|March 4, 2024
概括
这项研究详细介绍了一种新型细菌菌体,vB_Ab4_Hep4,有效对抗多药耐药的Acinetobacter baumannii. 它的尾部管状蛋白B中的突变扩大了菌体.
科学领域:
- 微生物学 微生物学
- 病毒学 病毒学
- 细菌治疗疗法是一种细菌治疗.
背景情况:
- 多种药物耐药的宝曼尼菌 (MDRAB) 构成了重大威胁.
- 菌体 (菌体) 是针对MDRAB感染的抗生素的潜在替代品.
- 体宿主范围的限制阻碍了它们的治疗应用.
研究的目的:
- 为了表征一种新的菌体,vB_Ab4_Hep4,针对MDRAB.
- 为了研究一个突变的菌体,vB_Ab4_Hep4-M.宿主范围扩张的机制.
- 阐明尾状管状蛋白在菌体宿主特异性中的作用.
主要方法:
- 临床菌体vB_Ab4_Hep4及其突变体vB_Ab4_Hep4-M.的分离和表征
- 基因分析以确定负责宿主范围扩张的突变.
- 尾部管状蛋白B的表达以确认突变效应.
- 鉴定细菌囊作为菌体受体.
主要成果:
- 一个自发突变的菌体,vB_Ab4_Hep4-M,表现出一个扩大的宿主范围.
- 尾部管状蛋白B基因 (Asp to His) 的单个G-to-C突变驱动了宿主范围的扩张.
- 细菌囊被确定为野生类型和突变菌体的受体.
- 尾管状蛋白B在确定A. baumannii菌体宿主特异性方面发挥着至关重要的作用.
结论:
- 菌体vB_Ab4_Hep4是对抗MDRAB的一种有前途的药物.
- 尾部管状蛋白质修饰提供了一种扩大菌体宿主范围的策略,以加强菌体治疗.
- 了解尾部管状依赖特异性是改进治疗潜力的菌体的关键.
相关概念视频
01:30Lytic Cycle of Bacteriophages
70.7K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.7K
00:43Lysogenic Cycle of Bacteriophages
62.2K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.2K